Mako Yamamoto
- Biotechnology top 0.5%
- Biomedical Engineering top 5%
- Genetics top 5%
- Molecular Biology
- Oncology top 10%
- Co-authors
- Robert M. HoffmanYukihiko HiroshimaMichael BouvetShinji MiwaShuya YanoFuminari UeharaYong ZhangMing Zhao
- Topics
- Cancer Research and Treatments (25 papers)Nanoplatforms for cancer theranostics (19 papers)Virus-based gene therapy research (15 papers)
- Partner nations
- JapanUnited StatesCzechia
In The Last Decade
Mako Yamamoto
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Biotechnology 735
- Biomedical Engineering 645
- Genetics 476
- Molecular Biology 441
- Oncology 261
Countries citing papers authored by Mako Yamamoto
This map shows the geographic impact of Mako Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mako Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mako Yamamoto more than expected).
Fields of papers citing papers by Mako Yamamoto
This network shows the impact of papers produced by Mako Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mako Yamamoto. The network helps show where Mako Yamamoto may publish in the future.
Co-authorship network of co-authors of Mako Yamamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Mako Yamamoto. A scholar is included among the top collaborators of Mako Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mako Yamamoto. Mako Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 104 | |
| 4 | 109 | |
| 5 | 80 | |
| 6 | 2 | |
| 7 | 62 | |
| 8 | 24 | |
| 9 | 8 | |
| 10 | 45 | |
| 11 | 37 | |
| 12 | 85 | |
| 13 | 10 | |
| 14 | 26 | |
| 15 | 1 | |
| 16 | 17 | |
| 17 | 23 | |
| 18 | 38 | |
| 19 | 16 | |
| 20 | 49 |
About Mako Yamamoto
Mako Yamamoto is a scholar working on Biotechnology, Genetics and Immunology and Allergy, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Research and Treatments (25 papers), Nanoplatforms for cancer theranostics (19 papers) and Virus-based gene therapy research (15 papers). The work is most often cited by research in Biotechnology (735 citations), Genetics (476 citations) and Biomedical Engineering (645 citations). Mako Yamamoto has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Robert M. Hoffman, Yukihiko Hiroshima, Michael Bouvet, Shinji Miwa, Shuya Yano, Fuminari Uehara, Yong Zhang, Ming Zhao, Takashi Murakami and Makoto Noda. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.